Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Researchers to study the genomics of Alzheimer's disease in people with African heritage

Researchers at the Case Western Reserve University School of Medicine, with colleagues from the John P. Hussman Institute for Human Genomics at the University of Miami, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, at Columbia University, and Wake Forest University School of Medicine will study the genomics of Alzheimer's disease (AD) in people with African heritage throughout the United States.

12 Aug 2021

Skin cells could provide better understanding of molecular mechanisms of frontotemporal dementia

A new study from the University of Eastern Finland suggests that skin fibroblasts from frontotemporal dementia patients may be useful in investigating underlying disease mechanisms as well as in biomarker and drug research.

12 Aug 2021

UQ-led telehealth project focuses on easing dementia’s burden on Indigenous Australians

Improving the impact of high dementia rates on Indigenous Australians and communities is the focus of a University of Queensland-led telehealth project with a global track record of success.

11 Aug 2021

Beige fat cells mediate subcutaneous fat's brain protection from dementia

Beige is considered a calming paint color, and scientists have new evidence that beige fat has a similar impact on the brain, bringing down the inflammation associated with the more common white fat and providing protection from dementia.

10 Aug 2021

Study uncovers startling evidence from coroners' inquests into suicides of older people in the 1700s

Previous studies of suicide in the 1700s have focussed on societal attitudes rather than the experiences of people who took their own lives. These suicides have largely been described as 'medicalised' acts driven by lunacy.

10 Aug 2021

Study explores ‘brain fog’ following COVID-19

A recent survey conducted in the United Kingdom revealed that approximately one in every five experiences prolonged coronavirus disease 2019 (COVID-19) symptoms five weeks post-infection. Also, one in seven people reported persistent symptoms even after twelve weeks.

10 Aug 2021

Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021

Ultra-sensitive Simoa® HD-X technology powers new findings that detect rapid reduction of plasma P-tau217 from donanemab, Lilly’s investigational antibody therapy for Alzheimer's disease at 12 weeks

From Quanterix 9 Aug 2021

Light therapy may speed up the healing of burns by activating growth protein

Light therapy may accelerate the healing of burns, according to a University at Buffalo-led study.

6 Aug 2021

Aducanumab approval for Alzheimer's may provide a proof of concept that can be rapidly improved upon

The recent US Food and Drug Administration (FDA) approval of aducanumab – which has the potential to treat Alzheimer's disease – may provide a proof of concept that can be rapidly improved upon, writes Dennis Selkoe in this Perspective.

6 Aug 2021

Clarity on covid count: Pandemic’s toll on seniors extended well beyond nursing homes

As covid-19 resurges across the country, driven by the highly infectious delta variant, experts are extending our understanding of the pandemic's toll on older adults — the age group hit hardest by the pandemic.

6 Aug 2021

Expert highlights the progress and challenges in developing blood tests for Alzheimer's disease

Given the progress in therapeutics for Alzheimer's disease (AD), including the recent approval of aducanumab – the first anti-amyloid immunotherapy approved by the FDA for the disease – there is a need for simple blood tests that could be used to ensure accurate diagnosis and assess therapeutic progress.

6 Aug 2021

Study reveals structural differences and unique polymorphs in amyloid-β fibrils

Alzheimer's disease (AD) is a neurological condition leading to dementia that worsens with age as patients exhibit cognitive, memory, and psychological deficits.

5 Aug 2021

Digital technology may become a standard tool for neuropsychological evaluations after COVID-19

The COVID-19 pandemic has significantly altered the delivery of health care including neuropsychological evaluations.

5 Aug 2021

Restoring cholesterol levels could be a new therapeutic approach for diseases linked to TDP-43 protein

Researchers in Singapore have discovered that brain cells cannot maintain the cholesterol-rich myelin sheath that protects and insulates neurons in the absence of a protein called TDP-43.

4 Aug 2021

Key protein linked to both physical fitness in youth and diseases of old age

Researchers from Johns Hopkins Medicine say they have added to evidence that a protein called CaMKII improves strength, endurance, muscle health and fitness in young animals.

4 Aug 2021

Study shows pharmacological rescue of mitochondrial defect related to Parkinson's disease

Treating mice that have a Parkinson's disease-causing mutation with a small molecule compound restores the removal of damaged mitochondria from their brain cells, shows a study published today in eLife.

3 Aug 2021

Analysis: Keto diets place pregnant women and kidney disease patients at risk of adverse health effects

In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects.

3 Aug 2021

Research group identifies 15 novel biomarkers linked to late-onset dementias

A study by an international research group identified 15 novel biomarkers that are linked to late-onset dementias. These biomarkers are proteins, which predict cognitive decline and subsequent increased risk of dementia already 20 years before the disease onset.

3 Aug 2021

Latin American and Caribbean research contributions to tackle challenges posed by brain diseases

Every year there are nearly ten million new cases of dementia globally, of which Alzheimer's Disease (AD) is the most common form, accounting for around 60-70% of cases.

2 Aug 2021

Existing drug may be effective in treating SARS-CoV-2

Scientists from the University of Chicago have found that the drug masitinib may be effective in treating COVID-19.

2 Aug 2021

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Researchers to study the genomics of Alzheimer's disease in people with African heritage

Skin cells could provide better understanding of molecular mechanisms of frontotemporal dementia

UQ-led telehealth project focuses on easing dementia’s burden on Indigenous Australians

Beige fat cells mediate subcutaneous fat's brain protection from dementia

Study uncovers startling evidence from coroners' inquests into suicides of older people in the 1700s

Study explores ‘brain fog’ following COVID-19

Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021

Light therapy may speed up the healing of burns by activating growth protein

Aducanumab approval for Alzheimer's may provide a proof of concept that can be rapidly improved upon

Clarity on covid count: Pandemic’s toll on seniors extended well beyond nursing homes

Expert highlights the progress and challenges in developing blood tests for Alzheimer's disease

Study reveals structural differences and unique polymorphs in amyloid-β fibrils

Digital technology may become a standard tool for neuropsychological evaluations after COVID-19

Restoring cholesterol levels could be a new therapeutic approach for diseases linked to TDP-43 protein

Key protein linked to both physical fitness in youth and diseases of old age

Study shows pharmacological rescue of mitochondrial defect related to Parkinson's disease

Analysis: Keto diets place pregnant women and kidney disease patients at risk of adverse health effects

Research group identifies 15 novel biomarkers linked to late-onset dementias

Latin American and Caribbean research contributions to tackle challenges posed by brain diseases

Existing drug may be effective in treating SARS-CoV-2

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in